抗逆转录病毒治疗启动后体重增加、性别与免疫激活的关联
研究基于两项大型随机试验中启动ART并达到病毒抑制的340名参与者,按体重维持或增加分组,检测7种炎症与免疫激活标志物。结果显示,在ART前BMI正常者中,体重增加与部分标志物基线水平较高相关;体重增加与96周标志物变化的关系因性别而异,女性体重增加者多数标志物下降幅度小于男性。
要点
- ART前BMI正常者中,体重增加与IL-6、sTNF-RI/RII、CXCL-10、sCD163、hsCRP基线较高相关。
- 体重增加后96周免疫激活标志物下降幅度存在性别差异,女性下降更小。
- 女性ART后体重增加可能伴随免疫激活消退延迟。
核心结论
- 在女性中,启动ART后体重增加与多种免疫激活标志物下降幅度减小相关。
研究设计与样本
- 对两项大型随机试验中启动ART的参与者进行目的性抽样,共纳入340人。
- 参与者需达到病毒学抑制,且体重维持(±0.5 kg/m2)或增加(2.6-6.4 kg/m2)至96周。
- 检测7种炎症与免疫激活标志物在第0周和第96周的水平。
- 采用多变量线性回归分析体重增加、性别及ART前BMI与标志物基线及变化的关系。
主要发现
- 340名参与者中位ART前年龄42岁,CD4+细胞计数273 cells/mm3,HIV-1 RNA 4.7 log10 copies/mL。
- 参与者中49%为女性,33%为白人,42%为黑人,24%为西班牙裔。
- ART前BMI正常者中,较高的IL-6、sTNF-RI和RII、CXCL-10、sCD163和hsCRP基线水平与体重增加相关。
- 体重增加与第96周这些标志物变化的关系因性别而异;体重增加的女性相比体重增加的男性,多数标志物下降幅度更小。
临床怎么用
- 对启动ART的女性患者,体重增加时需关注免疫激活标志物下降可能延迟。
- 临床监测体重变化时,可结合性别评估免疫激活消退情况。
局限性
- 研究为目的性抽样选取的参与者子集,可能不代表全部试验人群。
- 仅检测7种标志物,未涵盖全部免疫激活通路。
- 原文未报告样本量计算或统计效能相关细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immune activation persists despite suppressive antiretroviral therapy (ART) and may be affected by sex or body composition. We explored these relationships in a subset of participants who initiated ART in two large randomized trials. METHODS: Purposeful sampling selected participants who achieved virologic suppression on ART and either maintained weight within ± 0.5 kg/m2 or gained 2.6-6.4 kg/m2 from baseline to 96 weeks. We measured 7 markers of inflammation and immune activation at weeks 0 and 96. Multivariable linear regression explored associations of weight gain, sex, and pre-ART BMI with pre-ART and changes in biomarker concentrations. RESULTS: 340 participants were selected; median pre-ART age 42 years, CD4+ cell count 273 cells/mm3, HIV-1 RNA 4.7 log10 copies/mL; 49% were women, 33% white, 42% black, and 24% Hispanic. Among participants with a normal pre-ART BMI, higher pre-ART levels of IL-6, sTNF-RI and RII, CXCL-10, sCD163 and hsCRP were associated with weight gain. Association of weight gain with week 96 changes of these biomarkers differed by sex; women who gained weight had smaller declines in most measured biomarkers compared to men who gained. CONCLUSIONS: Among women, weight gain is associated with attenuated decline in several immune activation markers following ART initiation. Clinical Trials Registration. NCT00811954 and NCT00811954.
引用
- Bares SH, Smeaton LM, Scott SE, et al. The Association Between Weight Gain, Sex, and Immune Activation Following the Initiation of Antiretroviral Therapy. J Infect Dis. 2021. PMID: 33870433. doi:10.1093/infdis/jiab210
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。